WMAHSN is looking for a Medicines Safety Leadfor its Medicines Optimisation and Management programme, due to AHSN funding this will be offered as a 12 month fixed term contract.
December 2020
New Vacancy: WMAHSN Medicines Optimisation Lead
WMAHSN is looking for a Medicines Optimisation Lead for its Medicines Optimisation and Management programme, due to AHSN funding this will be offered as a 12 month fixed term contract.
The Meridian Celebration of Innovation Awards
Today, the West Midlands Academic Health Science Network is proud to announce the return of the prestigious Meridian Celebration of Innovation Awards, with entries now open.
West Midlands healthcare teams successfully complete international course in adoption of healthcare innovation
Two West Midlands based healthcare teams have become European Institute of Innovation & Technology (EIT) alumni after successfully graduating from the first cohort of the UP-rAISHe programme in December 2020.
2020/21 Pathway Transformation Fund (PTF)
Phase 3 of the Pathway Transformation Fund will launch on Friday (18 December), with applications open from Monday 4 January until midday on 30 April 2021.
Birmingham spinout Revitope Oncology Inc announces $10m investment
December 16, 2020: University of Birmingham spinout Revitope Oncology Inc has announced a $10m investment from leading Chinese biopharmaceutical company Junshi Biosciences.
Read "Birmingham spinout Revitope Oncology Inc announces $10m investment"
Free membership with Move it or Lose it
With funding from Sport England, Move it or Lose it has launched an online club to help older people stay active and connected while they are at home.
New vacancy: Digital Health Innovation Manager
We are now looking for a Digital health Innovation Manager to join our Digital health team. The individual must have excellent interpersonal skills and the ability to communicate effectively with stakeholders at all levels.
Patient safety in partnership
The AHSN Network has made a significant contribution during the first year of the NHS Patient Safety Strategy. An update on its patient safety plan – one year on outlines the impact it’s had improving safety in hospitals, maternity and neonatal units, care homes and the community.
Medilink Midlands CEO and Board Announced
Medilink Midlands has announced that its newly forged Board of Directors has appointed Dr Darren Clark as Chief Executive Officer and member of the Board of Directors, effective immediately. Darren previously held the position of Chief Executive Officer at Medilink East Midlands.
New vacancy: CVD Programme Manager
WMAHSN is looking for a Programme Manager for its Cardiovascular disease prevention and management programme, due to AHSN funding this will be offered as a 12 month fixed term contract.
AHSN Network has benefited more than 479,000 patients and generated £322.3 million inward investment for UK economy
The AHSN Network Impact Report 2018-2020 highlights outstanding impacts achieved by AHSNs and evidences how they are driving adoption and spread in healthcare innovation, transforming patient outcomes, enabling efficiencies, saving the NHS money, generating economic growth and attracting millions of pounds of investment for the country’s economy.
Spinout 4D Biomaterials ramps up commercialisation for 3D tissue scaffolds
4D Biomaterials has been awarded funding by Innovate UK for the development and commercialisation of a new class of liquid resins that can be custom-printed into bioresorbable 3D tissue scaffolds providing accelerated and improved wound healing following major surgery.
Read "Spinout 4D Biomaterials ramps up commercialisation for 3D tissue scaffolds"